Evidence map›Paper›PMID 29743170›Full record

SynthesisCirculation. Arrhythmia and electrophysiology2018

Clinical Implications of Ablation of Drivers for Atrial Fibrillation: A Systematic Review and Meta-Analysis.

Tina Baykaner, Albert J Rogers, Gabriela L Meckler, Junaid Zaman, Rachita Navara, Miguel Rodrigo, Mahmood Alhusseini, Christopher A B Kowalewski, Mohan N Viswanathan, Sanjiv M Narayan and 3 more

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Circulation. Arrhythmia and electrophysiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Focal Impulse and Rotor Modulation Ablation vs. Pulmonary Vein isolation for the treatment of paroxysmal Atrial Fibrillation: results from the FIRMAP AF study.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2021
    Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Re-recognized the maintenance mechanism of persistent atrial fibrillation via electrogram analysis in termination regions.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2025
    Article
  10. Observational
  11. Article
  12. Article
  13. Electrographic flow mapping of atrial fibrillation.Current opinion in cardiology · 2025
    Review
  14. Article
  15. Are drivers recurring or ephemeral? observations from serial mapping of persistent atrial fibrillation.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2024
    Article
  16. Article
  17. Navigating the Ebb and Flow of Atrial Fibrillation.JACC. Clinical electrophysiology · 2024
    Article
  18. Article
  19. Review
  20. Advanced Electroanatomic Mapping: Current and Emerging Approaches.Current treatment options in cardiovascular medicine · 2024
    Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Tina BaykanerDivision of Cardiology, Stanford Cardiovascular Institute, Stanford University School of Medicine, CA.
Albert J RogersDivision of Cardiology, Stanford Cardiovascular Institute, Stanford University School of Medicine, CA.
Gabriela L MecklerDivision of Cardiology, Stanford Cardiovascular Institute, Stanford University School of Medicine, CA.
Junaid ZamanDivision of Cardiology, Stanford Cardiovascular Institute, Stanford University School of Medicine, CA.
Rachita NavaraDivision of Cardiology, Stanford Cardiovascular Institute, Stanford University School of Medicine, CA.
Miguel RodrigoDivision of Cardiology, Stanford Cardiovascular Institute, Stanford University School of Medicine, CA.
Mahmood AlhusseiniDivision of Cardiology, Stanford Cardiovascular Institute, Stanford University School of Medicine, CA.
Christopher A B KowalewskiDivision of Cardiology, Stanford Cardiovascular Institute, Stanford University School of Medicine, CA.
Mohan N ViswanathanDivision of Cardiology, Stanford Cardiovascular Institute, Stanford University School of Medicine, CA.
Sanjiv M NarayanDivision of Cardiology, Stanford Cardiovascular Institute, Stanford University School of Medicine, CA.
Paul CloptonDivision of Cardiology, Stanford Cardiovascular Institute, Stanford University School of Medicine, CA.
Paul J WangDivision of Cardiology, Stanford Cardiovascular Institute, Stanford University School of Medicine, CA. pjwang@stanford.edu.
Paul A HeidenreichDivision of Cardiology, Stanford Cardiovascular Institute, Stanford University School of Medicine, CA.

Funding

The Dynamics of Human Atrial FibrillationR01HL083359 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Sanjiv M Narayan · 2008 to 2026
$7.9M
The Maintenance of Human Atrial FibrillationK24HL103800 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI NARAYAN, SANJIV M · 2010 to 2019
$1.9M
Impact of intermittent hypoxia on ventilatory drive and apnea severityR01HL085537 · NHLBI · WAYNE STATE UNIVERSITY · PI MATEIKA, JASON H. · 2007 to 2010
$1.5M
NHLBI NIH HHS K24 HL103800NHLBI NIH HHS R01 HL083359NHLBI NIH HHS R01 HL085537
6 · The paper itself

Abstract

backgroundThe outcomes from pulmonary vein isolation (PVI) for atrial fibrillation (AF) are suboptimal, but the benefits of additional lesion sets remain unproven. Recent studies propose ablation of AF drivers improves outcomes over PVI, yet with conflicting reports in the literature. We undertook a systematic literature review and meta-analysis to determine outcomes from ablation of AF drivers in addition to PVI or as a stand-alone procedure.

methodsDatabase search was done using the terms atrial fibrillation and ablation or catheter ablation and driver or rotor or focal impulse or FIRM (Focal Impulse and Rotor Modulation). We pooled data using random effects model and assessed heterogeneity with I

resultsSeventeen studies met inclusion criteria, in a cohort size of 3294 patients. Adding AF driver ablation to PVI reported freedom from AF of 72.5% (confidence interval [CI], 62.1%-81.8%;

conclusionsIn controlled studies, the addition of AF driver ablation to PVI supports the possible benefit of a combined approach of AF driver ablation and PVI in improving single-procedure freedom from all arrhythmias. However, most studies are uncontrolled and are limited by substantial heterogeneity in outcomes. Large multicenter randomized trials are needed to precisely define the benefits of adding driver ablation to PVI.

Indexed as

Catheter AblationAction PotentialsAdultAgedAtrial FibrillationFemaleHeart RateHumansMaleMiddle AgedProgression-Free SurvivalPulmonary VeinsRecurrenceRisk FactorsTime FactorsTreatment Outcomeablation, catheterarrhythmiaatrial fibrillationcohort studiesfreedommeta-analysisodds ratio

Identifiers

PMID29743170
PMCPMC6474343

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.